(Q45235157)

11 December 2017

title

What can be expected from antimicrobial de-escalation in the critically ill? (English)

1 reference

11 December 2017

1

Marin H Kollef

1 reference

11 December 2017

publication date

19 November 2013

1 reference

11 December 2017

published in

Intensive Care Medicine

1 reference

11 December 2017

volume

40

1 reference

11 December 2017

issue

1

1 reference

11 December 2017

page(s)

92-95

1 reference

Strategies to prevent antimicrobial resistance in the intensive care unit

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3154-Y

Experience with a clinical guideline for the treatment of ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3154-Y

Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3154-Y

Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3154-Y

Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3154-Y

Inappropriate antibiotic therapy in Gram-negative sepsis increases hospital length of stay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3154-Y

Reduction of broad-spectrum antibiotic use with computerized decision support in an intensive care unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3154-Y

Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3154-Y

Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3154-Y

Biomarker-guided de-escalation of empirical therapy is associated with lower risk for adverse outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3154-Y

A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3154-Y

Progress on the development of rapid methods for antimicrobial susceptibility testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-3154-Y

De-escalation therapy in ventilator-associated pneumonia

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00134-013-3154-Y

21 January 2018

https://pubmed.ncbi.nlm.nih.gov/24248604

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24248604

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24248604

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00134-013-3154-Y

1 reference

Dimensions Publication ID

11 December 2017

1038672271

0 references

1 reference